Linked from

The 178 pages that link to Pharmacokinetics, each with the reason it gives.

• Dietary supplementNarrower topic: This framework explains how supplement ingredients are absorbed, distributed, metabolized, and eliminated.

• BioavailabilityNarrower topic: Bioavailability is one part of the broader account of a drug's movement through the body.

• Selective serotonin reuptake inhibitorNarrower topic: An SSRI's concentration over time shapes dosing, interactions, and the onset of exposure.

• BenzodiazepineNarrower topic: Differences in metabolism and clearance help explain variation in benzodiazepine duration and accumulation.

• Drug metabolismNarrower topic: Drug metabolism is one of the processes that shapes a medicine’s course through the body.

• Therapeutic drug monitoringNarrower topic: These processes determine the concentration measured and how it changes after a dose.

• SedationNarrower topic: Drug onset, redistribution, and clearance help determine how long sedation lasts.

• ProdrugNarrower topic: Prodrug design alters the concentration profile of the active drug.

• First-pass effectNarrower topic: The first-pass effect is one determinant of a drug’s concentration over time.

• AlbendazoleNarrower topic: Its principles explain why food and tissue location affect albendazole exposure.

• DoxycyclineNarrower topic: Doxycycline’s absorption and long duration shape its dosing and interactions.

• Hormone replacement therapyNarrower topic: It explains why oral, injected, and transdermal hormone doses are not interchangeable.

• Enzyme replacement therapyNarrower topic: Rapid clearance helps explain why enzyme replacement often needs repeated infusions.

• PrednisoneNarrower topic: These processes determine prednisone exposure, activation, and duration of action.

• PsilocybinNarrower topic: It accounts for how ingested psilocybin becomes active psilocin and leaves the body.

• Drug toleranceNarrower topic: Its processes determine drug exposure and can change during repeated use.

• ValproateNarrower topic: Valproate’s protein binding, metabolism, and dose-dependent kinetics shape its effects and monitoring.

• CarbamazepineNarrower topic: Carbamazepine's changing blood levels and interactions depend on its absorption and metabolism.

• PropofolNarrower topic: Propofol's redistribution and clearance help explain its rapid onset and offset.

• Antidepressant discontinuation syndromeNarrower topic: Drug movement through the body helps account for differences in symptom onset and duration.

• Biological half-lifeNarrower topic: Biological half-life summarizes one part of a substance’s movement through the body.

• LamotrigineNarrower topic: Lamotrigine’s clearance changes substantially with interacting medicines and helps determine dosing.

• CeftriaxoneNarrower topic: Ceftriaxone’s long elimination half-life helps permit once-daily dosing.

• CYP2D6Narrower topic: CYP2D6 contributes to drug clearance and therefore can alter concentration-time profiles.

• FluoxetineNarrower topic: Fluoxetine’s long half-life shapes dosing, interactions, and discontinuation.

• Herb–drug interactionNarrower topic: Many herb–drug interactions change the amount of medicine reaching its site of action.

• Dosage formNarrower topic: Dosage-form design can change the concentration-time profile that pharmacokinetics describes.

• Gender-affirming hormone therapyNarrower topic: Hormone formulation and route affect how medication levels change between doses.

• DiphenhydramineNarrower topic: Absorption, metabolism, and elimination shape diphenhydramine’s duration and timing of effects.

• Drug overdoseNarrower topic: These processes determine how quickly a drug accumulates and how long toxic effects persist.

• Active metaboliteNarrower topic: Metabolite formation and clearance shape the timing and duration of drug effects.

• AmlodipineNarrower topic: Amlodipine’s gradual absorption and long elimination half-life shape its once-daily dosing.

• AripiprazoleNarrower topic: Its long half-life and metabolism shape aripiprazole dosing and interactions.

• Drug absorptionNarrower topic: Absorption is the entry phase in the processes pharmacokinetics describes.

• FamotidineNarrower topic: Famotidine’s absorption and kidney clearance shape its dosing and duration.

• Inhalational anestheticNarrower topic: It supplies the general framework for inhaled anesthetic uptake and washout.

• Subcutaneous injectionNarrower topic: It explains how an injection route shapes medicine concentration over time.

• Adenosine receptor antagonistNarrower topic: Exposure and duration determine how long receptor blockade persists.

• DextromethorphanNarrower topic: Its metabolism and clearance help explain differences in dextromethorphan effects.

• MidazolamNarrower topic: Midazolam’s rapid onset and variable duration depend on these processes.

• OmeprazoleNarrower topic: Omeprazole’s absorption and metabolism help explain its dosing and variation between individuals.

• RisperidoneNarrower topic: Risperidone's active metabolite and CYP2D6 metabolism help explain dose differences and drug interactions.

• AcetazolamideNarrower topic: Its rapid absorption and predominantly renal elimination shape acetazolamide dosing.

• Route of administrationNarrower topic: It connects route choice to a drug’s concentration over time.

• TheophyllineNarrower topic: Theophylline's variable clearance determines how long concentrations remain therapeutic or toxic.

• ClonidineNarrower topic: Clonidine's absorption and elimination influence dosing intervals and the timing of withdrawal effects.

• IsofluraneNarrower topic: Uptake and removal through the lungs shape isoflurane’s onset and offset.

• NitrofurantoinNarrower topic: Nitrofurantoin's distribution and renal elimination account for its high urinary concentrations.

• TemazepamNarrower topic: Temazepam's onset and duration depend on its movement through the body.

• TramadolNarrower topic: Tramadol’s metabolism and clearance influence its duration, exposure, and variability.